This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will provide $127,645 to Emory University to support patient-oriented research focused on preventing cardiometabolic disease in children. The goal is to enhance the ability of the principal investigator, Dr. Miriam Vos, to train and mentor new investigators in this area. The research aims to understand the physiological changes leading to metabolic dysfunction-associated steatotic liver disease in children and to test sugar reduction as a prevention strategy for this condition and accompanying insulin resistance and dyslipidemia. This award will also support the principal investigator's career development activities, including experience in NIH training grants, leadership training, and the application of genetics in patient-oriented research. The award period runs from August 15, 2024 to July 31, 2029.
Generated 3/4/25, 4:26 AM